Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Verena Schropp"'
Publikováno v:
Journal of Neuroinflammation, Vol 20, Iss 1, Pp 1-14 (2023)
Abstract Background The presence of meningeal ectopic lymphoid structures (ELS) in a subgroup of patients diagnosed with secondary progressive multiple sclerosis (SPMS) corresponds to a pronounced cortical inflammation and an aggravated disease cours
Externí odkaz:
https://doaj.org/article/8f1275952b394f88a46cbd27e0e90e46
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
There has been a growing interest in the presence and role of B cell aggregates within the central nervous system of multiple sclerosis patients. However, very little is known about the expression profile of molecules associated with these aggregates
Externí odkaz:
https://doaj.org/article/7974cc2a5c3747ad8c3e68a7e39814ff
Publikováno v:
Biomedicines, Vol 11, Iss 7, p 1969 (2023)
The occurrence of B cell aggregates within the central nervous system (CNS) has prompted the investigation of the potential sources of pathogenic B cell and T cell responses in a subgroup of secondary progressive multiple sclerosis (MS) patients. Nev
Externí odkaz:
https://doaj.org/article/61a69c74158a4efe99551eda64c3cc4c
Autor:
Verena Schropp, Jörn Rohde, Damiano M. Rovituso, Samir Jabari, Richa Bharti, Stefanie Kuerten
Publikováno v:
Journal of Neuroinflammation, Vol 16, Iss 1, Pp 1-15 (2019)
Abstract Background In a subgroup of patients suffering from progressive multiple sclerosis (MS), which is an inflammation-mediated neurodegenerative disease of the central nervous system (CNS), B cell aggregates were discovered within the meninges.
Externí odkaz:
https://doaj.org/article/9177913ddce94ea5871a3f244778c8db
Publikováno v:
Osteoarthritis and Cartilage Open, Vol 2, Iss 4, Pp 100124- (2020)
Objective: It is known that recombinant human gelsolin (rhuGSN) supports wound closure and migration processes in avascular tissue. Since articular cartilage degradation plays an important role in osteoarthritis (OA), we are investigating how rhuGSN
Externí odkaz:
https://doaj.org/article/86d0a6a91daf4f739e86cec99e3c9c06
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Neuroinflammation can be defined as an inflammatory response within the central nervous system (CNS) mediated by a complex crosstalk between CNS-resident and infiltrating immune cells from the periphery. Triggers for neuroinflammation not only includ
Externí odkaz:
https://doaj.org/article/733ee629a6d74bd387ae8bfb6bab9e3c
Autor:
Kathrin Bail, Quirin Notz, Damiano M. Rovituso, Andrea Schampel, Marie Wunsch, Tobias Koeniger, Verena Schropp, Richa Bharti, Claus-Juergen Scholz, Konrad U. Foerstner, Christoph Kleinschnitz, Stefanie Kuerten
Publikováno v:
Journal of Neuroinflammation, Vol 14, Iss 1, Pp 1-15 (2017)
Abstract Background MP4-induced experimental autoimmune encephalomyelitis (EAE) is a mouse model of multiple sclerosis (MS), which enables targeted research on B cells, currently much discussed protagonists in MS pathogenesis. Here, we used this mode
Externí odkaz:
https://doaj.org/article/a97a3e10901c467195921b9e3bf0034e
Autor:
Verena Schropp, Rittika Chunder, Arif B. Ekici, Philipp Kirchner, Sabine Tacke, Stefanie Kuerten, Eduard Urich
BackgroundSuccessful therapy with anti-CD20 monoclonal antibodies (mAbs) has reinforced the key role of B cells in the immunopathology of multiple sclerosis. While treatment with currently available anti-CD20 mAbs results in rapid and robust eliminat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::320ee76d3cda25cdc81dfa42101dafe9
https://doi.org/10.21203/rs.3.rs-776877/v1
https://doi.org/10.21203/rs.3.rs-776877/v1
Publikováno v:
Frontiers in Neurology
Frontiers in Neurology, Vol 11 (2020)
Frontiers in Neurology, Vol 11 (2020)
Neuroinflammation can be defined as an inflammatory response within the central nervous system (CNS) mediated by a complex crosstalk between CNS-resident and infiltrating immune cells from the periphery. Triggers for neuroinflammation not only includ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66d66a3581e8dd90c762aaf44b58153f
https://opus4.kobv.de/opus4-fau/files/15265/fneur-11-591894-g0001.tif
https://opus4.kobv.de/opus4-fau/files/15265/fneur-11-591894-g0001.tif
Autor:
Stefanie Kuerten, Henrik Zetterberg, Verena Schropp, Eduard Urich, Sabine Tacke, Kaj Blennow, Thomas Breakell
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 6864, p 6864 (2020)
International Journal of Molecular Sciences
Volume 21
Issue 18
International Journal of Molecular Sciences
Volume 21
Issue 18
B cell-depleting therapies have recently proven to be clinically highly successful in the treatment of multiple sclerosis (MS). This study aimed to determine the effects of the novel type II anti-human CD20 (huCD20) monoclonal antibody (mAb) obinutuz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::815bf3f835e96efeb1533050502f2607
https://www.mdpi.com/1422-0067/21/18/6864
https://www.mdpi.com/1422-0067/21/18/6864